Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...
The report found that confusion, duplication of work and a lack of leadership are contributing to a long term failure to meet cancer targets in Wales. | ITV National News ...